drug research

How to Approve 'Biosimilar' Drugs? The FDA Has to Figure That Out

Unlike generics, which are the exact chemical copies of a brand-name drug, biosimilars have large and often complex proteins that are made in living cells, and tiny differences can play havoc with the product. It may take years for the FDA to create an approval process.

Stocks in the News: Pfizer, Kraft, Cadbury, Hershey

News that could affect stock prices today: Pfizer and India's Strides Arcolab reached an agreement that will expand the off-patent generic drugs in the U.S. drug maker's portfolio; Kraft's hostile takeover bid for Cadbury received conditional antitrust approval by the European Union.